| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 05/06/2009 | EP1443961B1 Glycoprotein compositions |
| 05/06/2009 | EP1414525B1 2-(3,5-bis-trifluoromethyl-phenyl)-n-¬6-(1,1-dioxo-1.lambda.6-thiomorpholin-4-yl)-4-(2-methyl or 4-fluoro-2-methyl substituted)phenyl-pyridin-3-yl -n-methyl-isobutyramide |
| 05/06/2009 | EP1410022B1 Detection and treatment of prostate cancer |
| 05/06/2009 | EP1343782B1 Pyrimidineamines as angiogenesis modulators |
| 05/06/2009 | EP1308440B1 Piperidine derivatives and drugs containing these derivatives as the active ingredient |
| 05/06/2009 | EP1274851B1 A nucleic acid construct encoding a processing component derived from the n-terminal region of the hepatitis virus orf2, and an antigenic polypeptide |
| 05/06/2009 | EP1272193B1 Synergistic combination therapy for treating cancer |
| 05/06/2009 | EP1244435B9 Polyhydroxylated aromatic compounds for the treatment of amyloidosis and alpha-synuclein fibril diseases |
| 05/06/2009 | EP1200114B1 Ppar delta inhibitors for the treatment of cardiovascular diseases |
| 05/06/2009 | EP1152750B1 Spontaneously dispersible n-benzoyl staurosporine compositions |
| 05/06/2009 | EP1089724B1 Cyano substituted oleanolic acid derivatives as no production inhibitors |
| 05/06/2009 | CN101426904A Cancerous disease modifying antibodies 141205-05 |
| 05/06/2009 | CN101426815A Ligands that have binding specificity for egfr and/or vegf and methods of use therefor |
| 05/06/2009 | CN101426792A Pyrazolopyrimidines as therapeutic agents |
| 05/06/2009 | CN101426772A Benzotriazine inhibitors of kinases |
| 05/06/2009 | CN101426770A Imidazole derivatives for use as EDG-1 antagonists |
| 05/06/2009 | CN101426763A Sulfide and disulfide compounds and compositions for cholesterol management and related uses |
| 05/06/2009 | CN101426536A Method of treatment, prophylaxis and diagnosis of pathologies of the bone |
| 05/06/2009 | CN101426505A Dihydrothienopyrimidine for treating inflammatory disorders |
| 05/06/2009 | CN101423551A Isolated nucleic acid molecules which encode t cell inducible factors, or interleukin-21, the proteins encoded; and uses thereof |
| 05/06/2009 | CN101423546A Radioactive rhenium marked polypeptide containing RGD sequence as well as preparation method and application thereof |
| 05/06/2009 | CN101423540A Cytarabin 5'-O-L-valine ester and pharmaceutically acceptable salt as well as preparation and application thereof |
| 05/06/2009 | CN101423521A Method for preparing two isoflavones compounds and anti-tumor and anti-plant pathogen use thereof |
| 05/06/2009 | CN101423519A Tetrandrine organic acid salt as well as preparation method and application |
| 05/06/2009 | CN101423518A Imidazole derivates and medical use thereof |
| 05/06/2009 | CN101423517A Gamma-carbolines derivates as well as preparation method and application thereof |
| 05/06/2009 | CN101423516A Preparation of pidotimod sodium and medicinal use thereof |
| 05/06/2009 | CN101423513A Amine pyrimidine derivates, and production method thereof, and medicament composition and use |
| 05/06/2009 | CN101423500A Substituted benzoxazoles and analogues as estrogenic agents |
| 05/06/2009 | CN101423489A Indoline-2-one derivates and uses thereof |
| 05/06/2009 | CN101422723A Extraction method of flavonoid anti-tumor active ingredient in barbat skullcap |
| 05/06/2009 | CN101422619A New method for preventing tumor cell growth based on nucleus binding-protein gene silencing |
| 05/06/2009 | CN101422617A Use of ZNF268 gene splicing isomer in treating leukaemia |
| 05/06/2009 | CN101422615A Oridonin polymer micelle administration preparation and preparation method thereof |
| 05/06/2009 | CN101422613A Anti-cancer medicine containing low anticoagulant property heparin and taxol |
| 05/06/2009 | CN101422612A Method for increasing crocetin water solubility |
| 05/06/2009 | CN101422585A Pharmaceutical use of medicine composition containing zedoary turmeric oil |
| 05/06/2009 | CN101422553A Preparation method of anti-cancer traditional Chinese medicine and injection thereof |
| 05/06/2009 | CN101422551A Traditional Chinese medicine body scenting and building liquid |
| 05/06/2009 | CN101422534A Radio therapy sensitization composite preparation |
| 05/06/2009 | CN101422504A Preparation method of medicine red clover raw material for extracting isoflavone |
| 05/06/2009 | CN101422502A Preparation method of dogwood extract containing ursolic acid |
| 05/06/2009 | CN101422497A Ginsenoside Rb1 containing impurity Panax Notoginseng saponin R2 |
| 05/06/2009 | CN101422496A Capsules for auxiliary treating cancer |
| 05/06/2009 | CN101422489A Traditional Chinese medicine preparation for treating adenocarcinoma |
| 05/06/2009 | CN101422483A Medicine for suppressing breast cancer cell in-vitro growth and treating breast cancer |
| 05/06/2009 | CN101422478A Etoposide slow-release drop-pills and preparation method thereof |
| 05/06/2009 | CN101422466A Use of cucurbitacin in preparing medicine for treating cancer |
| 05/06/2009 | CN101422458A Epothilone freeze-drying composition |
| 05/06/2009 | CN101422455A Micro-emulsion injection containing EGCG |
| 05/06/2009 | CN101422454A Omega-3 polyunsaturated fatty acid tanshinone IIA sub-microemulsion and preparation method thereof |
| 05/06/2009 | CN101422451A 1-acetoxy-chavicol-acetate and derivates thereof with broad-spectrum anti-tumor activity |
| 05/06/2009 | CN101422439A Etoposide freeze-dry powder preparation for injection and preparation method thereof |
| 05/06/2009 | CN101422428A Injection containing sodium pidotimod |
| 05/06/2009 | CN101422425A Etretinate type medicine solid dispersion |
| 05/06/2009 | CN101422424A Mycophenolic acid medicine implantation agent and preparation method and use thereof |
| 05/06/2009 | CN101422268A Anti-cancer fish soup |
| 05/06/2009 | CN100484951C Panaxcoside secondary glucoside fatty acid ester compound, its preparation method and medicinal composition using said compound as active ingredient |
| 05/06/2009 | CN100484940C Water-soluble camptothecine derivative and its preparation process and application thereof |
| 05/06/2009 | CN100484934C Processes for preparing substituted pyrimidines and pyrimidine derivatives as inhibitors of protein kinase |
| 05/06/2009 | CN100484928C Thiadiazoline derivative |
| 05/06/2009 | CN100484575C Chromatin peptide medicinal molecule for sealing MYC cell proliferation path |
| 05/06/2009 | CN100484560C Sarcandra powder injection and preparing method thereof |
| 05/06/2009 | CN100484550C Chinese patent medicine for treating leukopenia due to tumor treating radiotherapy and chemotherapy, and preparation method thereof |
| 05/06/2009 | CN100484522C Chinese medicinal preparation for treating tumour and preparation process thereof |
| 05/06/2009 | CN100484520C 5-aminoketone valerate externally-applied preparation and production thereof |
| 05/06/2009 | CN100484513C Grafted nano carbon mixed suspension and its preparing process |
| 05/06/2009 | CN100484417C Health care bamboo salt and its preparing method |
| 05/05/2009 | US7528255 Hydroxy, ω-carboxyaryl substituted diphenyl ureas and dirivatives thereof as raf kinase inhibitors |
| 05/05/2009 | US7528224 Human Leucocyte antigen-A2 binding peptide having an amino acid sequence from a signal peptide encoded by the MUC-1 gene; immune reaction against tumor cells further increased by the simultaneous use of cytotoxic T cells directed against both peptides presented by MHC-1 molecules. |
| 05/05/2009 | US7528169 drugs separated from fermentation cultures of filamentous fungi, having angiogenesis inhibitory activity in a low oxygen condition |
| 05/05/2009 | US7528164 e.g. 2-Amino-4-(3-bromo-4,5-dimethoxyphenyl)-3-cyano-7-methyl-4H-pyrrolo [2,3-h]chromene; antiproliferative, antitumor, anticarcinogenic agent |
| 05/05/2009 | US7528162 such as 3-(4-Chlorophenyl)-N'-((4-chlorophenyl)sulfonyl)-N-(piperidin-1-yl)-4-phenyl-4,5-dihydro-1H-pyrazole-1-carboxamidine, used as cannabinoid (CB1) receptor antagonists, for prophylaxis of psychological disorders |
| 05/05/2009 | US7528152 synthetic analog of Hemiasterlin; anticarcinogenic agent; restenosis of blood vessels subject to traumas such as angioplasty and stenting; safe and effective, while retaining stability in biological media; exhibit low cytotoxicity to non-dividing normal cells |
| 05/05/2009 | US7528147 e.g. 2 {5,6-dimethoxy-1-[2-(4-methylpiperazin- 1 -yl)ethyl]-1H-indol-3 -yl}-1H-pyrrolo[2,3- b]pyridine; Insulin Growth Factor-1 (somatomedin) antagonist; antiproliferative, antitumor agent; solid tumor; prostate, lung and breast cancer |
| 05/05/2009 | US7528141 Use of cyclopenta[g]quinazoline derivatives for treating cancer |
| 05/05/2009 | US7528140 Substituted pyrrolo[3,2-d]pyrimidines as glycogen synthase kinase (GSK) inhibitors |
| 05/05/2009 | US7528139 Sulfonamides |
| 05/05/2009 | US7528138 Pyrazolo[1,5-a]pyrimidines useful as inhibitors of protein kinases |
| 05/05/2009 | US7528137 Compounds, compositions, and methods |
| 05/05/2009 | US7528132 immunodeficiencies, cancers, cardiovascular diseases, endocrine disorders, Parkinson's disease, metabolic diseases, tumorigenesis, Alzheimer's disease, heart disease, diabetes, neurodegeneration, inflammation, kidney disease, atherosclerosis and airway disease; indazolyl [1,2,4]triazine compounds |
| 05/05/2009 | US7528130 Cytotoxic agents comprising taxanes and their therapeutic use |
| 05/05/2009 | US7528116 Kinase suppressor of Ras inactivation for therapy of Ras mediated tumorigenesis |
| 05/05/2009 | US7527974 Preparing embryonic stem cells via nuclear transplantation; tissue engineering and the use of embryonic stem in diagnosis, prevention and treatment of cell proliferative, nervous system, muscular and bone disorders; tissue repair |
| 05/05/2009 | US7527969 Comprises purified imunoglobulin polypeptide or antigen binding fragment for diagnosis of disease/cancer |
| 05/05/2009 | US7527794 Nucleotide sequences coding immunoglobulin fusion specific to heparan sulfate proteoglycans for use as diagnostic and therapeutic tool in treatment and prevention of neurodegenerative and cell proliferative disorders |
| 05/05/2009 | US7527792 Arg-arg-leu-ser-tyr-ser-arg-arg-arg-phe decapeptide bonded to drug such as doxorubicin via maleimide derivative linkage; preventing chemoresistance or drug resistance; gene expression inhibition of multidrug resistance gene |
| 05/05/2009 | US7527789 Use of a preparation based on an antibody directed against a tumor-associated glycosylation |
| 05/05/2009 | US7527786 Monoclonal anti-idiotypic antibody; antitumor agents; anticarcinogenic agents; antiproliferative agents; immunotherapy; hormone antagonist therapy |
| 05/05/2009 | CA2448281C Optical resolution of (1-benzyl-4-methylpiperidin-3-yl)-methylamine and the use thereof for the preparation of pyrrolo 2,3-pyrimidine derivatives as protein kinases inhibitors |
| 05/05/2009 | CA2436260C Compositions containing a ruthenium(iii) complex and a heterocycle |
| 05/05/2009 | CA2253790C Methods of enhancing anti-tumour immunity in a mammal |
| 05/05/2009 | CA2234980C Cyclopeptide derivatives |
| 05/05/2009 | CA2149298C Flk-1 is a receptor for vascular endothelial growth factor |
| 04/30/2009 | WO2009055734A1 Condensed compounds with activity at estrogen receptors |
| 04/30/2009 | WO2009055674A1 Pyrrolopyrimidine alkynyl compounds and methods of making and using same |
| 04/30/2009 | WO2009055633A1 Hydrated crystalline esters of camptothecin for the treatment of cancer |
| 04/30/2009 | WO2009055506A2 Aminoflavone (nsc 686288) and combinations thereof for treating breast cancer |
| 04/30/2009 | WO2009055299A1 Substituted pyrimidine-5-carboxamide and 5-carboxylic ester kinase inhibitors |
| 04/30/2009 | WO2009055077A1 Tropane compounds |